Drug profile

The FDA adverse-event record for Cefovecin Sodium

2,721 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cefovecin Sodium. See the species affected, top reactions, and outcomes below.

2,721
adverse-event reports
19.4%
death-coded share
Cat
most-reported species
421
Anorexia - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
2,721
Total Reports
527
Deaths Reported
19.4%
Death Rate

Active Ingredients

Cefovecin Sodium

Administration Routes

SubcutaneousUnknownParenteralOtherIntramuscularTopicalOralIntravenousIntraocularRespiratory (Inhalation)

Species Affected

Cat 2,054
Dog 587
Unknown 67
Human 4
Guinea Pig 4
Mouse 1
Rabbit 1
Other 1
Ferret 1
Tiger 1

Most Affected Breeds

Domestic (unspecified) 752
Domestic Shorthair 726
Cat (unknown) 157
Domestic Longhair 106
Unknown 80
Domestic Mediumhair 62
Crossbred Canine/dog 58
Siamese 58
Chihuahua 46
Shih Tzu 43

Most Reported Reactions

Anorexia 421
Vomiting 364
Depression 294
Death 270
Death by euthanasia 239
Ataxia 221
Behavioural disorder NOS 208
Weight loss 202
Lack of efficacy (bacteria) - NOS 189
Anaemia NOS 182
Diarrhoea 175
Not eating 152

Outcome Breakdown

Outcome Unknown
418 (25.1%)
Died
417 (25.0%)
Recovered/Normal
370 (22.2%)
Ongoing
336 (20.1%)
Euthanized
110 (6.6%)
Recovered with Sequela
17 (1.0%)

Cefovecin Sodium Adverse Event Insights

2,721 reports name Cefovecin Sodium; 527 recorded a death outcome (19.4% of reported events, not a population-level mortality rate). Active ingredient: Cefovecin Sodium. Administration routes: Subcutaneous, Unknown, Parenteral, Other.

By species: Cat (2,054 reports), Dog (587 reports), Unknown (67 reports). By breed: Domestic (unspecified) (752), Domestic Shorthair (726), Cat (unknown) (157).

Leading clinical signs: Anorexia (421), Vomiting (364), Depression (294), Death (270). Outcome, 1,668 coded reports: Outcome Unknown leads at 25.1%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.